Tyrosine's place at the head of the catecholamine pathway
L-tyrosine is the amino acid from which the body builds dopamine, noradrenaline, and adrenaline. The pathway runs tyrosine to L-DOPA (the rate-limiting step, catalysed by tyrosine hydroxylase) to dopamine, and then onward to noradrenaline and adrenaline. Supplemental tyrosine is meant to keep the raw-material pool topped up so synthesis is not substrate-limited.
The diagram frames tyrosine as refilling a substrate pool rather than directly boosting neurotransmitter levels, which is the accurate framing: under normal conditions the rate-limiting enzyme, not substrate supply, controls how much catecholamine is made.
When topping up the pool seems to matter
Tyrosine's measurable benefits in human studies cluster around demanding, depleting conditions: acute stress, cold, sleep loss, or sustained mental effort, where catecholamine turnover is high and substrate may run short. In those settings some trials report better cognitive performance under pressure. In rested, unstressed people the effect is generally small or absent.
So it is best understood as buffering performance during depletion rather than as a general mood or focus enhancer. This is general educational information, not medical advice; people taking thyroid medication, MAO inhibitors, or with related conditions should consult a qualified professional first.